The management of primary central nervous system (PCNSL) is one of the most
controversial topics in neuro-oncology because of the complexity of the disease and the …

Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement
of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of …

Abstract 219 HIV-negative adults≤ 70 years with primary CNS lymphoma (PCNSL) were
enrolled in the randomized IELSG32 trial. Enrolled patients were randomly assigned to …

Primary central nervous system lymphoma (PCNSL) is a rare and frequently fatal lymphoma
subtype. The programmed death-1 (PD-1) pathway has emerged as a potential therapeutic …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …

Management of secondary central nervous system lymphoma Page 1 Br J Haematol. 2022;00:1–10.
| wileyonlinelibrary.com/journal/bjh BSH GOOD PRACTICE PAPER Management of …

Diffuse large B-cell lymphoma (DLBCL) is an aggressive B-cell lymphoma curable even in
advanced stages. DLBCL involving the central nervous system (CNS) is more difficult to cure …

Autologous hematopoietic cell transplantation (auto-HCT) has long been the standard
approach for patients with relapsed/refractory (R/R) chemosensitive diffuse large B cell …

Objective This study aimed to compare the accuracy of relative cerebral blood volume
(rCBV) and percentage signal recovery (PSR) obtained from high flip-angle dynamic …

Secondary central nervous system lymphoma (SCNSL) is a rare, aggressive disorder with a
historically dismal prognosis of< 6 months. 1 Patients may present de novo with systemic …